EG ·
SINEMET 25/250mg 20/TAB
SINEMET 25/250mg 20/TAB
Composition
These source-reported data require scientific review and are not treatment advice.
LEVODOPA
· AMOUNT_PER_UNIT
CARBIDOPA
· AMOUNT_PER_UNIT
LEVODOPA
· AMOUNT_PER_UNIT
CARBIDOPA
· AMOUNT_PER_UNIT
Registration
Packages and prices
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| SINEMET 25 /250 MG 10 TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| SINEMET 25 /250 MG 20 TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| SINEMET 25/250mg 10/TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| LECARDOPA 275MG 30 TAB | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis | — EGP |
| LEVOCAR 25025MG 10 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| SINEMET 10/100 MG 100 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| sineab | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| MADOPAR 250MG 100 CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| STALEVO 100MG/25MG/200MG 30/TAB # | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| SINEMET 25 / 250 MG 100 20TAB IMP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| LEVOCAR 25025MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| STALEVO 100/25/200MG 30/TAB#™ | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |